Form 424B3 - Prospectus [Rule 424(b)(3)]
2024年7月13日 - 6:12AM
Edgar (US Regulatory)
July 12, 2024 | Registration
Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(3) |
JPMorgan Chase Financial Company LLC
Structured Investments
Review Notes Linked to the MerQube US Large-Cap Vol
Advantage Index due May 17, 2029
Fully and Unconditionally Guaranteed by JPMorgan Chase
& Co.
Notwithstanding anything to the contrary set forth in
the pricing supplement dated May 14, 2024, related to the notes referred to above (the “pricing supplement”), the Call Value
and the Payment at Maturity are as set forth below:
Call
Value: The Call Value with respect to each Review Date is set forth below:
| · | first through sixteenth Review Dates: 100.00% of the Initial Value |
| · | final Review Date: 50.00% of the Initial Value |
Payment at Maturity:
If the notes have not been automatically called (and therefore
the Final Value is less than the Barrier Amount), your payment at maturity per $1,000 principal amount note will be calculated as follows:
$1,000 + ($1,000 × Index
Return)
If the notes have not been automatically called (and
therefore the Final Value is less than the Barrier Amount), you will lose more than 50.00% of your principal amount at maturity and could
lose all of your principal amount at maturity.
CUSIP: 48134X6R1
Investing in the notes involves a number of risks. See “Risk
Factors” beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, “Risk
Factors” beginning on page PS-11 of the accompanying product supplement, “Risk Factors” beginning on page US-4 of the
accompanying underlying supplement and “Selected Risk Considerations” beginning on page PS-6 of the pricing supplement.
Neither the Securities and Exchange Commission (the “SEC”)
nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this amendment,
the pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus
addendum. Any representation to the contrary is a criminal offense.
The notes are not bank deposits, are not insured by the Federal
Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.
You should read this amendment together with the pricing supplement
and the related product supplement, underlying supplement, prospectus supplement and prospectus and prospectus addendum, each of which
can be accessed via the hyperlinks below. Please also see “Additional Terms Specific to the Notes” in the pricing supplement.
· Pricing supplement dated May 14, 2024:
http://www.sec.gov/Archives/edgar/data/1665650/000121390024044353/ea174463_424b2.htm
· Product supplement no. 4-I dated April 13, 2023:
http://www.sec.gov/Archives/edgar/data/19617/000121390023029539/ea152803_424b2.pdf
· Underlying supplement no. 5-II dated March 5, 2024:
http://www.sec.gov/Archives/edgar/data/19617/000121390024020078/ea0200816-01_424b2.pdf
· Prospectus supplement and prospectus, each dated April 13, 2023:
http://www.sec.gov/Archives/edgar/data/19617/000095010323005751/crt_dp192097-424b2.pdf
· Prospectus addendum dated June 3, 2024:
http://www.sec.gov/Archives/edgar/data/1665650/000095010324007599/dp211753_424b3.htm
Amendment no. 1 to pricing supplement dated May 14, 2024
to product supplement no. 4-I dated April 13, 2023, underlying supplement no. 5-II dated March 5, 2024, the prospectus and prospectus
supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024
JP Morgan Chase (NYSE:JPM-M)
過去 株価チャート
から 9 2024 まで 10 2024
JP Morgan Chase (NYSE:JPM-M)
過去 株価チャート
から 10 2023 まで 10 2024